D
Lexeo Therapeutics, Inc. LXEO
$4.83 $0.173.65% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -22.91% -50.61% -82.73% -46.65% -58.00%
Total Depreciation and Amortization 2.82% 5.25% 6.33% 10.65% 11.21%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -110.01% 59.12% 228.06% 231.00% 193.70%
Change in Net Operating Assets 40.56% 67.91% -376.00% 62.14% -93.65%
Cash from Operations -35.07% -46.07% -102.60% -27.65% -52.76%
Capital Expenditure 49.30% -- 100.00% -2,666.67% -446.15%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -781,220.00% 195,100.00% -- 100.00% --
Cash from Investing -17,869.72% 8,182.90% -128,095.89% -56.60% -458.97%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -64.86% -45.87% -10.48% -3.74% 28.16%
Issuance of Common Stock 1,100.29% -99.81% -93.70% 30.00% 73,955.56%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -10.02% -- -8,284.00% -- --
Cash from Financing 24,972.16% -99.99% -100.10% -101.84% 409.57%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 132.71% -108.30% -241.84% -78.01% -50.69%